Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation

Mesenchymal‐epithelial transition (MET) pathway activation is associated with the mechanisms that influence properties affecting cancer cell survival and invasiveness. The MET exon 14 skipping mutation (METex14del) is found in 2%–3% of patients with non‐small cell lung cancer (NSCLC). Previous studi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Takamori, Shinkichi, Matsubara, Taichi, Fujishita, Takatoshi, Ito, Kensaku, Toyozawa, Ryo, Seto, Takashi, Yamaguchi, Masafumi, Okamoto, Tatsuro
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2021
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7952779/
https://ncbi.nlm.nih.gov/pubmed/33533182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13871
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados